Early treatment of chronic hepatitis B in children: Everything to play for?

J Hepatol. 2020 Apr;72(4):802-803. doi: 10.1016/j.jhep.2019.12.007. Epub 2020 Feb 14.

Authors

Antonio Bertoletti¹, Upkar S Gill², Patrick T F Kennedy²

Affiliations

¹ Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore, Singapore; Singapore Immunology Network, Singapore Agency for Science, Technology & Research (A*STAR), Singapore, Singapore. Electronic address: antonio@duke-nus.edu.sg.
² Barts Liver Centre, Immunobiology, Blizard Institute, Barts and The London, School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.

PMID: 32067804
DOI: 10.1016/j.jhep.2019.12.007

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antiviral Agents* / therapeutic use
Child
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Hepatitis B*
Hepatitis B, Chronic* / drug therapy
Humans

Substances

Antiviral Agents
Hepatitis B Surface Antigens
Hepatitis B e Antigens

Grants and funding

PB-PG-0614-34087/DH_/Department of Health/United Kingdom